Lasted News
Press Release
■ License acquired for sales and lease of specially controlled medical devices.
June 22, 2011
■ License acquired for the manufacture of pharmaceutical products (in vitro diagnostic products).
June 20, 2011
■ ISO13485 certification acquired (quality management systems for medical devices/in vitro diagnostic products).
March 03, 2011
■ License acquired for the sale and manufacture of pharmaceutical products (in vitro diagnostic products).
September 16, 2010
■ First-ever accreditation from the College of American Pathologists (CAP) in Japan for an independent facility carrying out contract genetic analysis.
May 12, 2010
■ “The Second-class Drugs Marketing Authorization Holder” and “The Second-class Medical Devices Marketing Authorization Holder” licenses from Tokyo Metropolitan Government.
February 25, 2010
As a result, RIKEN GENESIS is now authorized to manufacture and market pharmaceutical products including.
■ RIKEN GENESIS Collaborates with StaGen to offer SNP Genotyping Service:Comprehensive range of services now includes statistical analysis services based on statistical genetics.
January 27, 2010
Starting on September 1, 2009, RIKEN GENESIS Co., Ltd. completed an agreement with StaGen Co., Ltd. for a business tie-up to offer SNP (single nucleotide polymorphisms) genotyping services.